Transcription Factors MYOCD, SRF, Mesp1 and SMARCD3 Enhance the Cardio-Inducing Effect of GATA4, TBX5, and MEF2C during Direct Cellular Reprogramming

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Christoforou, Nicolas ^a   Chellappan, Malathi ^a   Adler, Andrew F ^a   Kirkton, Robert D ^a   Wu, Tianyi ^b   Addis, Russell C ^c   Bursac, Nenad ^a   Leong, Kam W ^a  

^a Duke University   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; JANUS KINASE INHIBITOR; PROTEIN MEF2C; PROTEIN MESP1; PROTEIN MYOCD; PROTEIN SMARCD3; PROTEIN SRF; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELLULAR REPROGRAMMING; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MEMBRANE STEADY POTENTIAL; MOUSE; NONHUMAN; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMOSOMAL PROTEINS, NON-HISTONE; CYTOSKELETON; ELECTROPHYSIOLOGICAL PHENOMENA; EMBRYO, MAMMALIAN; FIBROBLASTS; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE PROTEINS; MYOCYTES, CARDIAC; NIH 3T3 CELLS; NUCLEAR PROTEINS; NUCLEAR REPROGRAMMING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; SERUM RESPONSE FACTOR; SUS SCROFA; T-BOX DOMAIN PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84877985001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063577     Document Type: Article

References (63)

1. Murry CE, Reinecke H, Pabon LM, (2006) Regeneration gaps: observations on stem cells and cardiac repair. Journal of the American College of Cardiology 47: 1777-1785.
2. Laflamme MA, Murry CE, (2011) Heart regeneration. Nature 473: 326-335.
3. Burridge PW, Keller G, Gold JD, Wu JC, (2012) Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell stem cell 10: 16-28.
4. Maltsev VA, Rohwedel J, Hescheler J, Wobus AM, (1993) Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mechanisms of development 44: 41-50.
5. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. The Journal of clinical investigation 108: 407-414.
6. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
7. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
8. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, et al. (2008) Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118: 507-517.
9. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, et al. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation research 104: e30-41.
10. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, et al. (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142: 375-386.
11. Szabo E, Rampalli S, Risueno RM, Schnerch A, Mitchell R, et al. (2010) Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468: 521-526.
12. Olson EN, (2006) Gene regulatory networks in the evolution and development of the heart. Science 313: 1922-1927.
13. Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, et al. (2012) MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circulation research 110: 1465-1473.
14. Protze S, Khattak S, Poulet C, Lindemann D, Tanaka EM, et al. (2012) A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. Journal of molecular and cellular cardiology 53: 323-332.
15. Chen JX, Krane M, Deutsch MA, Wang L, Rav-Acha M, et al. (2012) Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circulation research 111: 50-55.
16. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, et al. (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485: 593-598.
17. Song K, Nam YJ, Luo X, Qi X, Tan W, et al. (2012) Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485: 599-604.
18. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, et al. (2009) Reprogramming of murine and human somatic cells using a single polycistronic vector. Proceedings of the National Academy of Sciences of the United States of America 106: 157-162.
19. Christoforou N, Miller RA, Hill CM, Jie CC, McCallion AS, et al. (2008) Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. The Journal of clinical investigation 118: 894-903.
20. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, et al. (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell stem cell 3: 340-345.
21. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D, (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872.
22. Barth AS, Kizana E, Smith RR, Terrovitis J, Dong P, et al. (2008) Lentiviral vectors bearing the cardiac promoter of the Na+-Ca2+ exchanger report cardiogenic differentiation in stem cells. Molecular therapy: the journal of the American Society of Gene Therapy 16: 957-964.
23. Kita-Matsuo H, Barcova M, Prigozhina N, Salomonis N, Wei K, et al. (2009) Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PloS one 4: e5046.
24. Tian L, Hires SA, Mao T, Huber D, Chiappe ME, et al. (2009) Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nature methods 6: 875-881.
25. Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, et al. (2008) A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell stem cell 3: 346-353.
26. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, et al. (2012) Fiji: an open-source platform for biological-image analysis. Nature methods 9: 676-682.
27. Welch P, (1967) The use of fast Fourier transform for the estimation of power spectra: A method based on time averaging over short, modified periodograms. Audio and Electroacoustics, IEEE Transactions on 15: 70-73.
28. Takeuchi JK, Bruneau BG, (2009) Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 459: 708-711.
29. Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, et al. (2008) Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell stem cell 3: 55-68.
30. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, et al. (2008) Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell stem cell 3: 69-84.
31. Small EM, Warkman AS, Wang DZ, Sutherland LB, Olson EN, et al. (2005) Myocardin is sufficient and necessary for cardiac gene expression in Xenopus. Development 132: 987-997.
32. Wang Z, Wang DZ, Pipes GC, Olson EN, (2003) Myocardin is a master regulator of smooth muscle gene expression. Proceedings of the National Academy of Sciences of the United States of America 100: 7129-7134.
33. Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, et al. (2004) Restricted inactivation of serum response factor to the cardiovascular system. Proceedings of the National Academy of Sciences of the United States of America 101: 17132-17137.
34. McFadden DG, Barbosa AC, Richardson JA, Schneider MD, Srivastava D, et al. (2005) The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner. Development 132: 189-201.
35. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S, (1999) The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126: 1269-1280.
36. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, et al. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature biotechnology 26: 1269-1275.
37. Subramaniam A, Gulick J, Neumann J, Knotts S, Robbins J, (1993) Transgenic analysis of the thyroid-responsive elements in the alpha-cardiac myosin heavy chain gene promoter. J Biol Chem 268: 4331-4336.
38. Kattman SJ, Huber TL, Keller GM, (2006) Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Developmental cell 11: 723-732.
39. Addis RC, Hsu FC, Wright RL, Dichter MA, Coulter DA, et al. (2011) Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PloS one 6: e28719.
40. McSpadden LC, Kirkton RD, Bursac N, (2009) Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level. American journal of physiology Cell physiology 297: C339-351.
41. de GrootJR, Veenstra T, Verkerk AO, Wilders R, Smits JP, et al. (2003) Conduction slowing by the gap junctional uncoupler carbenoxolone. Cardiovascular research 60: 288-297.
42. Tallini YN, Ohkura M, Choi BR, Ji G, Imoto K, et al. (2006) Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proceedings of the National Academy of Sciences of the United States of America 103: 4753-4758.
43. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, et al. (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105: 851-862.
44. Huang J, Min Lu M, Cheng L, Yuan LJ, Zhu X, et al. (2009) Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proceedings of the National Academy of Sciences of the United States of America 106: 18734-18739.
45. Niu Z, Iyer D, Conway SJ, Martin JF, Ivey K, et al. (2008) Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart. Proceedings of the National Academy of Sciences of the United States of America 105: 17824-17829.
46. Shin CH, Liu ZP, Passier R, Zhang CL, Wang DZ, et al. (2002) Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110: 725-735.
47. Chen F, Kook H, Milewski R, Gitler AD, Lu MM, et al. (2002) Hop is an unusual homeobox gene that modulates cardiac development. Cell 110: 713-723.
48. Soonpaa MH, Field LJ, (1998) Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circulation research 83: 15-26.
49. Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, et al. (2009) Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462: 595-601.
50. Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, et al. (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nature cell biology 13: 215-222.
51. Chen J, Liu J, Chen Y, Yang J, Liu H, et al. (2011) Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell research 21: 884-894.
52. Carey BW, Markoulaki S, Hanna JH, Faddah DA, Buganim Y, et al. (2011) Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell stem cell 9: 588-598.
53. Ke Q, Xiao YF, Bradbury JA, Graves JP, Degraff LM, et al. (2007) Electrophysiological properties of cardiomyocytes isolated from CYP2J2 transgenic mice. Molecular pharmacology 72: 1063-1073.
54. Xiao YF, TenBroek EM, Wilhelm JJ, Iaizzo PA, Sigg DC, (2006) Electrophysiological characterization of murine HL-5 atrial cardiomyocytes. American journal of physiology Cell physiology 291: C407-416.
55. Heubach JF, Graf EM, Leutheuser J, Bock M, Balana B, et al. (2004) Electrophysiological properties of human mesenchymal stem cells. The Journal of physiology 554: 659-672.
56. Pijnappels DA, Schalij MJ, Ramkisoensing AA, van Tuyn J, de Vries AA, et al. (2008) Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circulation research 103: 167-176.
57. Bernheim L, Liu JH, Hamann M, Haenggeli CA, Fischer-Lougheed J, et al. (1996) Contribution of a non-inactivating potassium current to the resting membrane potential of fusion-competent human myoblasts. The Journal of physiology 493 (Pt 1): 129-141.
58. Iannaccone ST, Li KX, Sperelakis N, (1987) Transmembrane electrical characteristics of cultured human skeletal muscle cells. Journal of cellular physiology 133: 409-413.
59. Chilton L, Ohya S, Freed D, George E, Drobic V, et al. (2005) K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. American journal of physiology Heart and circulatory physiology 288: H2931-2939.
60. Rook MB, van Ginneken AC, de Jonge B, el Aoumari A, Gros D, et al. (1992) Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs. The American journal of physiology 263: C959-977.
61. Huang J, Min Lu M, Cheng L, Yuan LJ, Zhu X, et al. (2009) Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proc Natl Acad Sci U S A 106: 18734-18739.
62. Xing W, Zhang TC, Cao D, Wang Z, Antos CL, et al. (2006) Myocardin induces cardiomyocyte hypertrophy. Circ Res 98: 1089-1097.
63. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, et al. (2010) Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107: 294-304.